Build your European commercial foundation before you build a full team
The Market Entry Sprint is a focused, fixed-scope engagement for CDMOs and pharma service companies that want to enter Europe with more clarity, stronger positioning and a credible commercial starting point.
In 4 to 8 weeks, UpstreamBG helps you sharpen your value proposition, define the right target accounts, structure your messaging and build a practical 6-12 months roadmap for Europe.
Fixed-fee format · 4 to 8 weeks
Designed as a low-risk entry offer
Why market entry often stalls
Strong capabilities are not enough. Many technically credible organisations struggle in Europe because their message is unclear, their targeting is too broad, or their commercial approach is not adapted to European buyers. UpstreamBG is built to close that gap.
Unclear positioning
Your capabilities are real, but your message is still too generic, too technical or not differentiated enough.
Weak commercial focus
You attend conferences or speak to prospects, but activity does not convert into a structured pipeline.
No local commercial bridge
You want to build traction in Europe without immediately hiring a full local business development team.
What the Sprint is
This is a short, high-value engagement designed to make your company commercially readable before wider European deployment. It is particularly relevant for organisations that do not yet have a structured message, a clear European segmentation, or a practical go-to-market sequence.What you will get:
Fixed-fee entry offer
4 to 8 week engagement
Focused on clarity, positioning and target selection
Built to reduce risk before active business development
Natural bridge toward a retainer-based commercial mandate
Contact usWhat’s included
The sprint gives you the essential commercial foundation needed to approach Europe in a more disciplined and credible way. Core deliverables in the UpstreamBG model include account segmentation, value proposition work, ICP definition, messaging, target lists, events and associations mapping, and a 6-12 Months roadmap.
Value Proposition
Clarify how your offer should be positioned for European biotech and pharma buyers.
ICP Definition
Define the customer profiles, buyer types and account categories that matter most.
Target Segmentation
Identify priority segments and build a first-wave target account logic.
Messaging & Argumentation
Develop sharper commercial language, proof points and talking tracks.
Events & Market Access Priorities
Select the most relevant conferences, associations and visibility channels.
6-12 Months Roadmap
Turn strategy into a practical next-step sequence for European activation.
Why UpstreamBG
UpstreamBG is not a generic consulting firm. The model is built around outsourced European business development and commercial representation for APAC CDMOs and pharma service companies. The value lies in combining market access, senior-level business development and technical credibility across complex biopharma services.
Clients do not just need introductions. They need clearer positioning, better commercial judgment, more credible European messaging and a partner able to connect technical capability with qualified market traction.
Commercial terms
Engagement Type:
from 8.000€ / Fixed Fee
This format is intentionally simple and decision-friendly. It is designed to lower the barrier to entry for clients who need market clarity before committing to a broader retained engagement.
Start Now- 4 to 8 weeks
- Fixed-fee entry offer
- Events & Market Access Priorities
- 6-12 Months Roadmap
Frequently asked questions
Here are some common questions about the service
It is a structured market-entry and commercial preparation engagement. The objective is to make your company commercially ready for Europe, before broader active business development begins.
The standard duration is 4 to 8 weeks, depending on the complexity of your offer and the scope of the target market.
You receive practical commercial outputs: sharper positioning, clearer segmentation, target priorities, messaging foundations and a 6-12 months market-entry roadmap.
If the foundations are ready, the sprint can naturally lead into a broader outsourced business development or European representation mandate. UpstreamBG explicitly positions it as an entry offer and a conversion tool toward retainer-based support.
Considering Europe, but not ready to build a full local commercial team?
Start with a Market Entry Sprint and build the commercial foundation before moving into active European business development.